CDC Oct. 22 webinar on COVID-19 and patients with substance use disorder
The Centers for Disease Control and Prevention Oct. 22 at 2 p.m. ET will host a Clinician Outreach and Communication Activity webinar on improving clinicians’ understanding the relationship between COVID-19 and the concerns of people who use drugs or who have a substance use disorder.
Subject matter experts also will highlight existing resources and exceptions for clinicians who prescribe medications for opioid use disorder, existing community-based linkages to care resources and the outpatient telemedicine experience from the perspective of front-line providers. Join the webinar here using ID 160 928 8166. A recording will be available for viewing on the COCA Call webpage a few hours after the live event concludes.
Related News Articles
Headline
A study published March 18 by Science Advances estimated that more than 155,000 U.S. COVID-19 deaths were uncounted during the COVID-19 pandemic. Researchers…
Headline
The cigarette smoking rate among U.S. adults dropped to 9.9% in 2024, the lowest level ever recorded, according to a report by the New England Journal of…
Headline
A study published by BMJ found that glucagon-like peptide-1 (GLP-1) drugs could help reduce the risk of various substance use disorders, including for alcohol…
Headline
The Substance Abuse and Mental Health Services Administration announced March 6 that it will award $69.1 million in grants for mental health and suicide…
Headline
The Centers for Disease Control and Prevention Feb. 19 released a report on the low use of COVID-19 antiviral drugs among individuals age 65 and older, a…
Headline
The Department of Health and Human Services Office for Civil Rights Feb. 13 announced the launch of a program to implement and enforce statutory and regulatory…